Everett Hits Rival Acella With Supplement Patent Suit

Law360, Washington (July 15, 2013, 3:59 PM EDT) -- Everett Laboratories Inc. slammed Acella Pharmaceuticals LLC with a patent infringement suit in New Jersey federal court on Friday, alleging Acella has created illegal copies of its Strovite One nutritional supplement and is rapidly usurping its market.

According to Everett, Acella's Choice-Tabs nutritional supplement product is virtually identical to its prescription-only Strovite One caplets, and the cheaper Acella pills infringe on an Everett patent-in-suit. The New Jersey-based nutritional supplement company alleges computerized drug databases have already linked the two products, causing retail chains across the country...
To view the full article, register now.